|
1.
|
|
22 p, 4.7 MB |
Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
/
Olivan, M (Hospital Universitari Vall d'Hebron) ;
García, Marta (Institut de Recerca Sant Joan de Déu) ;
Suárez, Leticia (Hospital Universitari Vall d'Hebron) ;
Guiu, Marc (Institut de Recerca Biomèdica) ;
Gros, Laura (Hospital Universitari Vall d'Hebron) ;
Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ;
Rigau, Marina (Hospital Universitari de Bellvitge) ;
Reventós, Jaume (Hospital Universitari de Bellvitge) ;
Segura, Miguel F. (Hospital Universitari Vall d'Hebron) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
de la Cruz, Xavier (Hospital Universitari Vall d'Hebron) ;
Gomis, Roger R. (Hospital Universitari de Bellvitge) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Rodríguez-Barrueco, Ruth (Hospital Universitari de Bellvitge) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most prevalent cancer in males worldwide, and it was the fifth leading cause of cancer mortality in this group in 2020. Near 70% of advanced-stage PCa patients will undergo bone metastasis, suffering pathological complications that severely affect patients' quality of life and probably progress in most cases to lethal PCa. [...]
2021 -  10.3390/cancers13246202
Cancers, Vol. 13 (december 2021)
|
|
|
2.
|
|
36 p, 6.3 MB |
Look-alike humans identified by facial recognition algorithms show genetic similarities
/
Joshi, Ricky S. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rigau, M. (Barcelona Supercomputing Center) ;
García-Prieto, Carlos A (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Castro de Moura, Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Piñeyro, David (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Moran, S (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Davalos, Veronica (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Carrión, P. (Institut de Biologia Evolutiva (UPF-CSIC) (Barcelona)) ;
Ferrando-Bernal, Manuel (Institut de Biologia Evolutiva (UPF-CSIC) (Barcelona)) ;
Olalde, I. (Institut de Biologia Evolutiva (UPF-CSIC) (Barcelona)) ;
Lalueza-Fox, Carles (Institut de Biologia Evolutiva (UPF-CSIC) (Barcelona)) ;
Navarro, Arcadi 1969- (Institució Catalana de Recerca i Estudis Avançats) ;
Fernández-Tena, C. (Herta Security. S.L.) ;
Aspandi, D. (Universitat Pompeu Fabra. Departament de Tecnologies de la Informació i les Comunicacions) ;
Sukno, F.M. (Universitat Pompeu Fabra. Departament de Tecnologies de la Informació i les Comunicacions) ;
Binefa i Valls, Xavier (Universitat Pompeu Fabra. Departament de Tecnologies de la Informació i les Comunicacions) ;
Valencia, A. (Institució Catalana de Recerca i Estudis Avançats) ;
Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
The human face is one of the most visible features of our unique identity as individuals. Interestingly, monozygotic twins share almost identical facial traits and the same DNA sequence but could exhibit differences in other biometrical parameters. [...]
2022 - 10.1016/j.celrep.2022.111257
Cell reports, Vol. 40 Núm. 8 (23 2022) , p. 111257
|
|
|
3.
|
|
16 p, 1.3 MB |
Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventós Puigjaner, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. [...]
2013 - 10.1155/2013/283635
BioMed Research International, Vol. 2013 (november 2013)
|
|
|
4.
|
|
17 p, 5.0 MB |
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Chiva, Cristina (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia-Grau, Iolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Diaz, Sherley (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Bijnsdorp, Irene (Department of Urology, VU University Medical Center, Amsterdam, The Netherlands) ;
Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ;
Di Mauro, Primiano (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Borrós, Salvador (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Reventós, Jaume (Institut d'Investigació Biomèdica de Bellvitge) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Paciucci, Rosanna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pegtel, Michiel (Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sabidó, Eduard (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. [...]
2016 - 10.18632/oncotarget.13634
Oncotarget, Vol. 8 (november 2016) , p. 4960-4976
|
|
|
5.
|
|
12 p, 3.0 MB |
Exosome-like vesicles in uterine aspirates : a comparison of ultracentrifugation-based isolation protocols
/
Campoy Moncayo, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lanau Angulo, Lucia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Altadill, Tatiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cubo-Abert, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez-Benavente, Assumpció (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia, Angel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Borrós, Salvador (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ponce, Jordi (Hospital Universitari de Bellvitge) ;
Matias-Guiu, Xavier (Institut de Recerca Biomèdica de Lleida) ;
Reventós, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Uterine aspirates are used in the diagnostic process of endometrial disorders, yet further applications could emerge if its complex milieu was simplified. Exosome-like vesicles isolated from uterine aspirates could become an attractive source of biomarkers, but there is a need to standardize isolation protocols. [...]
2016 - 10.1186/s12967-016-0935-4
Journal of translational medicine, Vol. 14 (june 2016)
|
|
|
6.
|
|
60 p, 3.6 MB |
Biological properties of extracellular vesicles and their physiological functions
/
Yáñez-Mó, María (Universidad Autónoma de Madrid, Departamento de Biología Molecular) ;
Siljander, Pia R.-M. (University of Helsinki. Department of Biosciences) ;
Andreu, Zoraida (Universidad Autónoma de Madrid, Departamento de Biología Molecular) ;
Zavec, Apolonija Bedina (National Institute of Chemistry (Ljubljana)) ;
Borràs i Serres, Francesc Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Buzás, Edit I (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ;
Buzas, Krisztina (University of Szeged. Faculty of Dentistry) ;
Casal, Enriqueta (CIC bioGUNE) ;
Cappello, Francesco (Euro-Mediterranean Institute of Science and Technology (Palermo)) ;
Carvalho, Joana (Institute of Molecular Pathology and Immunology of the University of Porto) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cordeiro-da-Silva, Anabela (University of Porto. Department of Biological Sciences) ;
Fais, Stefano (National Institute of Health. Department of Therapeutic Research and Medicines Evaluation (Rome)) ;
Falcón Pérez, Juan M. (CIC bioGUNE) ;
Ghobrial, Irene M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Giebel, Bernd (University Hospital Essen (Alemanya)) ;
Gimona, Mario (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ;
Graner, Michael (University of Colorado Denver. Department of Neurosurgery) ;
Gursel, Ihsan (Bilkent University. Department of Molecular Biology and Genetics) ;
Gursel, Mayda (Middle East Technical University. Department of Biological Sciences) ;
Heegaard, Niels H. H. (Statens Serum Institut. Department of Clinical Biochemistry, Immunology & Genetics) ;
Hendrix, An (Universitair Ziekenhuis Gent) ;
Kierulf, Peter (Oslo University Hospital (Oslo, Noruega)) ;
Kokubun, Katsutoshi (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Kosanovic, Maja (University of Belgrade. Institute for the Application of Nuclear Energy) ;
Kralj-Iglic, Veronika (University of Ljubljana. Faculty of Health Sciences) ;
Krämer-Albers, Eva-Maria (University of Mainz. Molecular Cell Biology and Focus Program Translational Neurosciences) ;
Laitinen, Saara (Finnish Red Cross Blood Service) ;
Lässer, Cecilia (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ;
Lener, Thomas (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine) ;
Ligeti, Erzsébet (Semmelweis University. Department of Physiology) ;
Linē, Aija (Latvian Biomedical Research and Study Centre) ;
Lipps, Georg (University of Applied Sciences and Arts Northwestern Switzerland. Institute of Chemistry and Bioanalytics) ;
Llorente, Alicia (Oslo University Hospital - The Norwegian Radium Hospital. Institute for Cancer Research) ;
Lötvall, Jan (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ;
Manček-Keber, Mateja (EN→FIST Centre of Excellence (Ljubljana)) ;
Marcilla, Antonio (Universitat de València. Departament de Biologia Cel·lular, Biologia Funcional i Antropologia Física) ;
Mittelbrunn, Maria (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Nazarenko, Irina (University of Freiburg. Institute for Environmental Health Sciences and Hospital Infection Control Medical Center) ;
Nolte-'t Hoen, Esther N. M. (Utrecht University. Department of Biochemistry and Cell Biology) ;
Nyman, Tuula A. (University of Helsinki. Institute of Biotechnology) ;
O'Driscoll, Lorraine (Trinity College Dublin. School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oliveira, Carla (University of Porto. Department of Pathology and Oncology) ;
Pállinger, Éva (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ;
Del Portillo, Hernando A.. (Institució Catalana de Recerca i Estudis Avançats) ;
Reventós, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rohde, Eva (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ;
Sammar, Marei (ORT Braude College. Department of Biotechnology Engineering) ;
Sánchez-Madrid, Francisco (Instituto de Investigación Hospital Universitario de la Princesa) ;
Santarém, N. (IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto) ;
Schallmoser, Katharina (Uniklinikum Salzburg. University Clinic of Blood Group Serology and Transfusion Medicine) ;
Ostenfeld, Marie Stampe (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Stoorvogel, Willem (Utrecht University. Department of Biochemistry and Cell Biology) ;
Stukelj, Roman (University of Ljubljana. Laboratory of Clinical Biophysics) ;
Van der Grein, Susanne G. (Utrecht University. Department of Biochemistry and Cell Biology) ;
Vasconcelos, M. Helena (University of Porto. Department of Biological Sciences) ;
Wauben, Marca H. M. (Utrecht University. Department of Biochemistry and Cell Biology) ;
De Wever, Olivier (Universitair Ziekenhuis Gent) ;
Universitat Autònoma de Barcelona
In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity to transfer proteins, lipids and nucleic acids, thereby influencing various physiological and pathological functions of both recipient and parent cells. [...]
2015 - 10.3402/jev.v4.27066
Journal of extracellular vesicles, Vol. 4 (2015)
|
|
|
7.
|
|
11 p, 2.3 MB |
Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
/
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia, M.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sequeiros, T. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Planas, J. (Hospital Universitari Vall d'Hebron) ;
Placer, José (Hospital Universitari Vall d'Hebron) ;
Reventós, J. (Institut d'Investigació Biomèdica de Bellvitge) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morote Robles, Juan. (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Nowadays prostate cancer is the most common solid tumor in men from industrialized countries and the second leading cause of death. At the ages when PCa is usually diagnosed, mortality related to cardiovascular morbidity is high; therefore, men at risk for PCa frequently receive chronic lipid-lowering and antiplatelet treatment. [...]
2015 - 10.1155/2015/762178
BioMed Research International, Vol. 2015 (january 2015)
|
|
|
8.
|
|
30 p, 2.0 MB |
The Present and Future of Prostate Cancer Urine Biomarkers
/
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Llauradó i Miravall, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Cooper, Colin (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ;
Reventós, Jaume (Universitat Internacional de Catalunya. Departament de Ciències Bàsiques) ;
Clark, Jeremy (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca)
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. [...]
2013 - 10.3390/ijms140612620
International journal of molecular sciences, Vol. 14 (june 2013) , p. 12620-12649
|
|
|
9.
|
|
2 p, 153.4 KB |
Un nou biomarcador per a la detecció del càncer de pròstata en orina
/
Rigau Resina, Marina (Hospital Universitari Vall d'Hebron)
El càncer de pròstata és el tipus de càncer més freqüent que afecta a la població masculina. El mètode diagnòstic utilitzat actualment és la detecció en sèrum de PSA (antigen prostàtic específic), el tacte rectal i la posterior biòpsia en cas de sospita. [...]
El cáncer de próstata es el tipo de cáncer más frecuente que afecta a la población masculina. El método diagnóstico utilizado actualmente es la detección en suero de PSA (antígeno prostático específico), el tacto rectal y la posterior biopsia en caso de sospecha. [...]
2011
UAB divulga, Juliol 2011, p. 1-2
2 documents
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
